Bulgaria Ministry of Health to absorb National Council for Drug Pricing

Bulgarian Health Minister Katya Ivkova has assured that the upcoming liquidation of the National Council for Pricing and Reimbursement of Medicinal Products (NCPRP) will not disrupt the pharmaceutical market or patient access to treatment. The Council's functions are set to be transferred directly to the Ministry of Health to ensure administrative continuity.

In response to inquiries from Member of Parliament Alexander Simidchiev, the Ministry stated that specialized expertise and personnel will be integrated into the Ministry to maintain institutional capacity. The restructuring aims to uphold legal certainty, ensuring that all statutory timeframes for pricing decisions and inclusion in the Positive Drug List remain in effect.

The Ministry emphasized that the new organizational structure will comply with European Directive 89/105/EEC, which mandates transparency and efficiency in pharmaceutical pricing procedures. The transition is designed to prevent delays in commercial procedures or the processing of medicinal documentation.